DermaPure® saves 18 year old’s leg from frost bite & is featured on US TV Programme

Tissue Regenix Group plc (AIM:TRX) ("Tissue Regenix" or "the Group"), the regenerative medical devices company, announces that DermaPure®, which is used in the treatment of chronic and acute wounds, has been featured in a US TV programme ‘The Balancing Act®’ highlighting its role in helping to save 18 year old Marty Smithson’s leg from frostbite.


During the programme Dr Marc Robins, specialist in Wound and Hyperbaric Medicine from Salt Lake City, Utah discusses recent medical advancements, including DermaPure®, to manage challenging cases from trauma wounds to treating diabetic foot ulcers. Diabetes affects 26 million people in the US and 25% of these will develop foot ulcers.

Antony Odell, CEO of Tissue Regenix
This programme highlights the tremendous advance represented by DermaPure® and its capacity to heal many types of wounds, including old chronic wounds which are traditionally more challenging to treat.  DermaPure has performed extremely well both in our study into acute wounds and across many other type of wounds arising from conditions such as traumatic injury, skin infections, and post-surgical deficits remaining after cancer removal. The efficacy of DermaPure® has been tested in some incredibly tough cases by clinicians across America and this particular case provides another example of why we have such confidence in our product.
Antony Odell, CEO of Tissue Regenix